MAM
TEVA icon

McCarthy Asset Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

McCarthy Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-150
Closed -$1K – 357
2021
Q3 		$1K Hold
150
– – ﹤0.01% 331
2021
Q2 		$1K Hold
150
– – ﹤0.01% 389
2021
Q1 		$2K Hold
150
– – ﹤0.01% 316
2020
Q4 		$1K Buy
+150
New +$1.44K ﹤0.01% 324

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

McCarthy Asset Management's TEVA Position: Q4 2021 in Review

McCarthy Asset Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2021, closing a stake of 150 shares — an estimated $1K sold.

McCarthy Asset Management first reported a position in TEVA in Q4 2020 and held it in 4 quarters. The position peaked at $2K in Q1 2021. 450 funds tracked by Wall St. Rank hold TEVA as of Q4 2021.

  • McCarthy Asset Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2021 after selling out during the quarter.
  • McCarthy Asset Management sold 150 Teva Pharmaceutical Industries Limited shares in Q4 2021, an estimated $1K.
  • McCarthy Asset Management first reported a position in Teva Pharmaceutical Industries Limited in Q4 2020 and held it in 4 quarters.
  • McCarthy Asset Management's Teva Pharmaceutical Industries Limited position peaked at $2K in Q1 2021.
  • 450 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2021.

Based on McCarthy Asset Management's 13F filing for Q4 2021, filed 7 Feb 2022.